Water Zone

Waterstone Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for metabolic and endocrine diseases. The company leverages its research and development capabilities in both the United States and China to advance a pipeline of small molecule candidates targeting prevalent conditions such as type 2 diabetes and dyslipidemia. Their lead programs include novel GLP-1 receptor agonists and DPP-4 inhibitors designed to improve glycemic control and metabolic health. Waterstone aims to bridge global pharmaceutical innovation with the rapidly growing healthcare market in Asia through strategic partnerships and efficient clinical development.